Abstract
The single oral dose pharmacokinetics of carbamazepine-10, 11-epoxide (CBZ-E) were investigated in six normal volunteers during a control session and during concurrent treatment with valpromide (VPM) (300 mg twice daily for 8 days). VPM caused a prolongation of the CBZ-E half-life from 6.4 +/- 1.4 to 20.5 +/- 6.3 h and decreased CBZ-E clearance from 73.5 +/- 20.0 to 23.5 +/- 4.0 ml h-1 kg-1 (P less than 0.01). These results suggest that the elevation of plasma CBZ-E levels in patients receiving carbamazepine and VPM in combination is due to inhibition of epoxide hydrolase in the liver.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bertilsson L., Tomson T. Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine-10,11-epoxide. An update. Clin Pharmacokinet. 1986 May-Jun;11(3):177–198. doi: 10.2165/00003088-198611030-00001. [DOI] [PubMed] [Google Scholar]
- Bialer M., Rubinstein A., Raz I., Abramsky O. Pharmacokinetics of valpromide after oral administration of a solution and a tablet to healthy volunteers. Eur J Clin Pharmacol. 1984;27(4):501–503. doi: 10.1007/BF00549603. [DOI] [PubMed] [Google Scholar]
- Meijer J. W., Binnie C. D., Debets R. M., van Parys J. A., de Beer-Pawlikowski N. K. Possible hazard of valpromide-carbamazepine combination therapy in epilepsy. Lancet. 1984 Apr 7;1(8380):802–802. doi: 10.1016/s0140-6736(84)91325-4. [DOI] [PubMed] [Google Scholar]
- Pacifici G. M., Franchi M., Bencini C., Rane A. Valpromide inhibits human epoxide hydrolase. Br J Clin Pharmacol. 1986 Sep;22(3):269–274. doi: 10.1111/j.1365-2125.1986.tb02886.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pacifici G. M., Tomson T., Bertilsson L., Rane A. Valpromide/carbamazepine and risk of teratogenicity. Lancet. 1985 Feb 16;1(8425):397–398. doi: 10.1016/s0140-6736(85)91417-5. [DOI] [PubMed] [Google Scholar]
- Pisani F., Di Perri R., Nistico G. Rapid quantitation of N-dipropylacetamide in human plasma by gas-liquid chromatography. J Chromatogr. 1979 Jun 1;174(1):231–233. doi: 10.1016/s0021-9673(00)87059-4. [DOI] [PubMed] [Google Scholar]
- Pisani F., Fazio A., Oteri G., Di Perri R. A study on the metabolism of dipropylacetamide to dipropylacetic acid in rats. J Pharm Pharmacol. 1982 Jan;34(1):45–46. doi: 10.1111/j.2042-7158.1982.tb04676.x. [DOI] [PubMed] [Google Scholar]
- Pisani F., Fazio A., Oteri G., Ruello C., Gitto C., Russo F., Perucca E. Sodium valproate and valpromide: differential interactions with carbamazepine in epileptic patients. Epilepsia. 1986 Sep-Oct;27(5):548–552. doi: 10.1111/j.1528-1157.1986.tb03582.x. [DOI] [PubMed] [Google Scholar]
- Tomson T., Tybring G., Bertilsson L. Single-dose kinetics and metabolism of carbamazepine-10,11-epoxide. Clin Pharmacol Ther. 1983 Jan;33(1):58–65. doi: 10.1038/clpt.1983.8. [DOI] [PubMed] [Google Scholar]